CVS Health To Boost Access To FDA-approved Nasal Naloxone For Patients Without Insurance
July 29, 2016 at 13:34 PM EDT
CVS Health Inc. (NYSE: CVS) and Adapt Pharma today revealed a fresh alliance to make the opioid overdose-reversing drug NARCAN Nasal ...